+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Nutritional Supplement Market

  • PDF Icon

    Report

  • 327 Pages
  • January 2024
  • Region: Europe
  • Astute Analytica
  • ID: 5969511
UP TO OFF until Jan 31st 2025

Europe Nutritional Supplement Market: Set to Reach US$ 63.51 Bn by 2030 with a CAGR of 7.84%

The Europe Nutritional Supplement Market is poised for a substantial expansion, with its value expected to grow from US$ 38.27 Bn in 2023 to US$ 63.51 Bn by 2030. This growth, at a CAGR of 7.84%, reflects an increasing consumer focus on health and wellness across Europe.

Growth Influencers:

The market growth is primarily driven by a soaring demand for sports nutritional and dietary supplements. Additionally, a growing consumer awareness about health and nutrition, coupled with the declining quality of diet, is prompting people to turn to supplements to fill nutritional gaps. However, the market faces challenges with issues of consumer trust, stemming from false labeling and the presence of counterfeit products in the market. These factors pose a significant hindrance to market growth.

Segment Overview:

The market is segmented based on product type, ingredient, form, age group, end use, and distribution channel.

By Product Type

  • Dietary Supplements
  • Beverages
  • Functional Nutrition
  • Infant & Maternal Nutrition
  • Medical Nutrition
  • Sports Supplements
  • Nutritional Supplements
  • Others

By Ingredient

  • Vitamins
  • Botanicals
  • Minerals
  • Proteins & Amino Acids
  • Fibers & Specialty Carbohydrates
  • Omega Fatty Acids
  • Others

By Form

  • Capsule
  • Powder
  • Tablet
  • Liquid
  • Others

By Age Group

  • Infants
  • Adults

By End Use

  • Energy & Weight Management
  • General Health
  • Bone & Joint Health
  • Gastrointestinal Health
  • Immunity
  • Cardiac Health
  • Diabetes
  • Anti-cancer
  • Others

By Distribution Channel

  • Hypermarkets & Supermarkets
  • Pharmacy Stores Treatment
  • Online Channels
  • Others
Leading segments include Dietary Supplements, commanding over 40% market share, and Proteins & Amino Acids, expected to grow at a CAGR of 10.72%. Tablet forms are set to cross US$ 18.33 Bn by 2028, while the Adults segment remains the largest consumer base. The Immunity segment is witnessing the fastest growth in end-use, and Pharmacy Stores Treatment is emerging as a key distribution channel.

Regional Overview:

Western Europe dominates the market, with significant contributions from countries like the UK, Germany, France, Italy, and Spain. This region is the stronghold of the European Nutritional Supplement Market, accounting for more than 80% of the market share in 2023. With a diverse range of products and an increasing focus on health and wellness, countries like the UK, Germany, France, Italy, and Spain are major contributors to the market's growth. Below are the countries covered in the report:

  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Belgium
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe

Company Profile:

The market is characterized by the presence of prominent players like Abbott Laboratories, Amway, Bayer AG, Glanbia, GlaxoSmithKline, and Pfizer. These companies, holding nearly 47% of the market share, are crucial in driving innovation and meeting consumer demand.

Report Insights:

  • The market is projected to reach US$ 63.51 Bn by 2030.
  • Dietary Supplements and Proteins & Amino Acids are key growth segments.
  • Consumer concerns over product authenticity pose a challenge.
  • Western Europe remains the most significant market region.

Questions to be Answered:

  • What are the driving factors behind the growth of the European Nutritional Supplement Market?
  • What are the key challenges faced by the market?
  • How do various segments contribute to the market dynamics?
  • What role do major companies play in the market?

Table of Contents

Chapter 1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
Chapter 2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Europe Nutritional Supplement Market
Chapter 4. Europe Nutritional Supplement Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Technology Solution Providers
4.1.2. Value Added Resellers
4.1.3. End-Users
4.2. Technology Roadmap
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. COVID-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2017 - 2030
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2021
4.8.3. Competitor Mapping
Chapter 5. Europe Nutritional Supplement Market Analysis, By Product Type
5.1. Key Insights
5.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
5.2.1. Dietary Supplements
5.2.2. Beverages
5.2.3. Functional Nutrition
5.2.4. Infant & Maternal Nutrition
5.2.5. Medical Nutrition
5.2.6. Sports Supplements
5.2.7. Nutritional Supplements
5.2.8. Others
Chapter 6. Europe Nutritional Supplement Market Analysis, By Ingredient
6.1. Key Insights
6.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
6.2.1. Vitamins
6.2.2. Botanicals
6.2.3. Minerals
6.2.4. Proteins & Amino Acids
6.2.5. Fibers & Specialty Carbohydrates
6.2.6. Omega Fatty Acids
6.2.7. Others
Chapter 7. Europe Nutritional Supplement Market Analysis, By Form
7.1. Key Insights
7.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
7.2.1. Capsule
7.2.2. Powder
7.2.3. Tablet
7.2.4. Liquid
7.2.5. Others
Chapter 8. Europe Nutritional Supplement Market Analysis, By Age Group
8.1. Key Insights
8.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
8.2.1. Infants
8.2.2. Adults
Chapter 9. Europe Nutritional Supplement Market Analysis, By End-Use
9.1. Key Insights
9.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
9.2.1. Energy & Weight Management
9.2.2. General Health
9.2.3. Bone & Joint Health
9.2.4. Gastrointestinal Health
9.2.5. Immunity
9.2.6. Cardiac Health
9.2.7. Diabetes
9.2.8. Anti-cancer
9.2.9. Others
Chapter 10. Europe Nutritional Supplement Market Analysis, By Distribution Channel
10.1. Key Insights
10.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
10.2.1. Hypermarkets & Supermarkets
10.2.2. Pharmacy Stores
10.2.3. Online Channels
10.2.4. Others
Chapter 11. Europe Nutritional Supplement Market Analysis, By Region/Country
11.1. Key Insights
11.2. Market Size and Forecast, 2017 - 2030 (US$ Bn) 11.2.1. Western Europe
11.2.1.1. The UK
11.2.1.2. Germany
11.2.1.3. France
11.2.1.4. Italy
11.2.1.5. Spain
11.2.1.6. Belgium
11.2.1.7. Rest of Western Europe
11.2.2. Eastern Europe
11.2.2.1. Poland
11.2.2.2. Russia
11.2.2.3. Rest of Eastern Europe
Chapter 12. The UK Nutritional Supplements Market Analysis 12.1. Key Insights
12.2.1. By Product Type
12.2.2. By Ingredient
12.2.3. By Form
12.2.4. By Age Group
12.2.5. By End-Use
12.2.6. By Distribution Channel
Chapter 13. Germany Nutritional Supplements Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
13.2.1. By Product Type
13.2.2. By Ingredient
13.2.3. By Form 13.2.4. By Age Group
13.2.5. By End-Use
13.2.6. By Distribution Channel
Chapter 14. France Nutritional Supplements Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
14.2.1. By Product Type
14.2.2. By Ingredient
14.2.3. By Form
14.2.4. By Age Group
14.2.5. By End-Use 14.2.6. By Distribution Channel
Chapter 15. Italy Nutritional Supplements Market Analysis
15.1. Key Insights
15.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
15.2.1. By Product Type
15.2.2. By Ingredient
15.2.3. By Form
15.2.4. By Age Group
15.2.5. By End-Use
15.2.6. By Distribution Channel
Chapter 16. Spain Nutritional Supplements Market Analysis
16.1. Key Insights
16.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
16.2.1. By Product Type
16.2.2. By Ingredient
16.2.3. By Form
16.2.4. By Age Group
16.2.5. By End-Use
16.2.6. By Distribution Channel
Chapter 17. Belgium Nutritional Supplements Market Analysis
17.1. Key Insights
17.2. Market Size and Forecast, 2017 - 2030 (US$ Bn) 17.2.1. By Product Type
17.2.2. By Ingredient
17.2.3. By Form
17.2.4. By Age Group
17.2.5. By End-Use
17.2.6. By Distribution Channel
Chapter 18. Rest of Western Europe Nutritional Supplements Market Analysis
18.1. Key Insights
18.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
18.2.1. By Product Type
18.2.2. By Ingredient
18.2.3. By Form
18.2.4. By Age Group
18.2.5. By End-Use 18.2.6. By Distribution Channel
Chapter 19. Russia Nutritional Supplements Market Analysis
19.1. Key Insights
19.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
19.2.1. By Product Type
19.2.2. By Ingredient
19.2.3. By Form
19.2.4. By Age Group
19.2.5. By End-Use
19.2.6. By Distribution Channel
Chapter 20. Poland Nutritional Supplements Market Analysis
20.1. Key Insights
20.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
20.2.1. By Product Type
20.2.2. By Ingredient
20.2.3. By Form
20.2.4. By Age Group
20.2.5. By End-Use
20.2.6. By Distribution Channel
Chapter 21. Rest of Eastern Europe Nutritional Supplements Market Analysis 21.1. Key Insights
21.2. Market Size and Forecast, 2017 - 2030 (US$ Bn)
21.2.1. By Product Type
21.2.2. By Ingredient
21.2.3. By Form
21.2.4. By Age Group
21.2.5. By End-Use
21.2.6. By Distribution Channel
Chapter 22. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook) 22.1. Abbott Laboratories
22.2. Archer Daniels Midland
22.3. Amway
22.4. Arkopharma Laboratoires Pharmaceutiques
22.5. Bayer
22.6. Bionova Lifesciences
22.7. Carlyle Group
22.8. Gla 22.13. Himalaya Drug Company
22.14. Nature's Sunshine Form
22.15. The Bounty Company
22.16. Other Prominent Players
nbia
22.9. GlaxoSmithKline
22.10. Nu Skin Enterprises
22.11. Pfizer
22.12. Herbalife International

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Archer Daniels Midland
  • Amway
  • Arkopharma Laboratoires Pharmaceutiques
  • Bayer
  • Bionova Lifesciences
  • Carlyle Group
  • Glanbia
  • GlaxoSmithKline
  • Nu Skin Enterprises
  • Pfizer
  • Herbalife International
  • Himalaya Drug Company
  • Nature's Sunshine Form
  • The Bounty Company

Table Information